Home / Latest Reports / Bio Artificial Pancreas Market

Bio-Artificial Pancreas Market By Type and End User- Global Industry Analysis & Forecast to 2027

Published On : January 2019 Pages : 130 Category: Medical Devices Report Code : HC012399

Request Sample Inquiry Before Buying Request for Customization Check Discount

Bio-Artificial Pancreas Market By Type (CTT (Control to Target) Systems and CTR (Control to Range) Systems), and By End User (Medical Centers, Hospital and Others)- Global Industry Analysis & Forecast to 2027        

Industry Outlook and Trend Analysis

Artificial organs are human-made bio-fake organs, which are embedded into the body to supplant or bolster natural organs. Artificial organs incorporate fake heart, kidney, pancreas, and cochlear inserts. They are made of biocompatible materials, for example, polymers, biologics, pottery, and metals. Counterfeit pancreas is embedded with various advancements, for example, sensors, biomaterials, and imaginative conveyance frameworks. Additionally, artificial pancreas play out the capacity same as the natural pancreas and enables the patient to carry on with a quality life. In today’s world artificial human body organs are gaining demand as they have been helping humans lead their life irrespective of all the disorders they have faced.

Drivers and Restraints

Factors like the rising number of cases of sort 1 diabetes, expanding interest for insulin self-organization, and rising geriatric populace drive the artificial pancreas market towards development. increment in the consciousness of the populace and joint effort of FDA with private organizations fuel the market development. In any case, absence of talented experts in immature locales, for example, Africa and South America are required to ruin the development of the market. Research and development in the field of medicinal gear is foreseen to make new open doors amid the projected time frame.

Regional Insights

Asia pacific is required to show the quickest development amid the estimated time frame. This region has most elevated number of diabetes patients attributable to the way of life, hereditary alteration, and urbanization and maturing.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Medtronic Plc
  • Insulet Corp
  • F. Hoffmann-La Roche Ltd
  • Bigfoot Biomedical, Inc.
  • Dexcom, Inc.
  • Johnson & Johnson
  • Tandem Diabetes Care
  • Beta Bionics
  • Inreda Diabetic B.V.
  • Cellnovo

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Bio-Artificial Pancreas Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o    Control to Target) Systems

o    CTR (Control to Range) Systems

·         Bio-Artificial Pancreas Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o    Medical Centers

o    Hospital

o    Others

·         Bio-Artificial Pancreas Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Bio-Artificial Pancreas Market, By Country

o    U.S. Bio-Artificial Pancreas Market

o    Canada Bio-Artificial Pancreas Market

o    Mexico Bio-Artificial Pancreas Market

o    Europe

§  Europe Bio-Artificial Pancreas Market, By Country

o    Germany Bio-Artificial Pancreas Market

o    UK Bio-Artificial Pancreas Market

o    France Bio-Artificial Pancreas Market

o    Russia Bio-Artificial Pancreas Market

o    Italy Bio-Artificial Pancreas Market

o    Rest of Europe Bio-Artificial Pancreas Market

o    Asia-Pacific

§  Asia-Pacific Bio-Artificial Pancreas Market, By Country

o    China Bio-Artificial Pancreas Market

o    Japan Bio-Artificial Pancreas Market

o    South Korea Bio-Artificial Pancreas Market

o    India Bio-Artificial Pancreas Market

o    Southeast Asia Bio-Artificial Pancreas Market

o    Rest of Asia-Pacific Bio-Artificial Pancreas Market

o    South America

§  South America Bio-Artificial Pancreas Market

o    Brazil Bio-Artificial Pancreas Market

o    Argentina Bio-Artificial Pancreas Market

o    Columbia Bio-Artificial Pancreas Market

o    Rest of South America Bio-Artificial Pancreas Market

o    Middle East and Africa

§  Middle East and Africa Bio-Artificial Pancreas Market

o    Saudi Arabia Bio-Artificial Pancreas Market

o    UAE Bio-Artificial Pancreas Market

o    Egypt Bio-Artificial Pancreas Market

o    Nigeria Bio-Artificial Pancreas Market

o    South Africa Bio-Artificial Pancreas Market

o    Rest of MEA Bio-Artificial Pancreas Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Bio-Artificial Pancreas Market, By Type

5.1.     Introduction

5.2.     Global Bio-Artificial Pancreas Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Bio-Artificial Pancreas Revenue and Revenue Share by Type (2017-2027)

5.3.     Control to Target) Systems

5.3.1.  Global Control to Target) Systems Revenue and Growth Rate (2017-2027)

5.4.     CTR (Control to Range) Systems

5.4.1.  Global CTR (Control to Range) Systems Revenue and Growth Rate (2017-2027)

6.       Bio-Artificial Pancreas Market, By End User

6.1.     Introduction

6.2.     Global Bio-Artificial Pancreas Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Bio-Artificial Pancreas Revenue and Revenue Share by End User (2017-2027)

6.3.     Medical Centers

6.3.1.  Global Medical Centers Revenue and Growth Rate (2017-2027)

6.4.     Hospitals

6.4.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

6.5.     Others

6.5.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Bio-Artificial Pancreas Market, By Region

7.1.     Introduction

7.2.     Global Bio-Artificial Pancreas Revenue and Market Share by Regions

7.2.1.  Global Bio-Artificial Pancreas Revenue by Regions (2017-2027)

7.3.     North America Bio-Artificial Pancreas by Countries

7.3.1.  North America Bio-Artificial Pancreas Revenue and Growth Rate (2017-2027)

7.3.2.  North America Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Bio-Artificial Pancreas by Countries

7.4.1.  Europe Bio-Artificial Pancreas Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Bio-Artificial Pancreas by Countries

7.5.1.  Asia-Pacific Bio-Artificial Pancreas Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Bio-Artificial Pancreas by Countries

7.6.1.  South America Bio-Artificial Pancreas Revenue and Growth Rate (2017-2027)

7.6.2.  South America Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Bio-Artificial Pancreas by Countries

7.7.1.  Middle East and Africa Bio-Artificial Pancreas Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Medtronic Plc

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Insulet Corp

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     F. Hoffmann-La Roche Ltd

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Bigfoot Biomedical Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Dexcom Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Johnson & Johnson

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Tandem Diabetes Care

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Beta Bionics

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Inreda Diabetic B.V.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Cellnovo

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

9.       Global Bio-Artificial Pancreas Market Competition, by Manufacturer

9.1.     Global Bio-Artificial Pancreas Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Bio-Artificial Pancreas Price By Region (2017-2017)

9.3.     Top 5 Bio-Artificial Pancreas Manufacturer Market Share

9.4.     Market Competition Trend

10.    Bio-Artificial Pancreas Market Forecast (2017-2027)

10.1. Global Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Bio-Artificial Pancreas Market Forecast by Regions (2017-2027)

10.2.1.      North America Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.1.1. United States Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.1.2. Canada Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.1.3. Mexico Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.2.      Europe Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.2.1. Germany Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.2.2. France Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.2.3. UK Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.2.4. Russia Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.2.5. Italy Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.3.1. China Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.3.2. Japan Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.3.3. Korea Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.3.4. India Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.4.      South America Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.4.1. Brazil Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.4.2. Argentina Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.4.3. Columbia Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.4.4. Rest of South America Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.3. Egypt Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.4. Nigeria Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.5. South Africa Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.6. Turkey Bio-Artificial Pancreas Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Bio-Artificial Pancreas Market Forecast (2017-2027)

10.3. Bio-Artificial Pancreas Market Forecast by Type (2017-2027)

10.3.1.      Bio-Artificial Pancreas Forecast by Type (2017-2027)

10.3.2.      Bio-Artificial Pancreas Market Share Forecast by Type (2017-2027)

10.4. Bio-Artificial Pancreas Market Forecast by End User (2017-2027)

10.4.1.      Bio-Artificial Pancreas Forecast by End User (2017-2027)

10.4.2.      Bio-Artificial Pancreas Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Bio-Artificial Pancreas Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Bio-Artificial Pancreas Revenue and Revenue Share by Type (2017-2018)
Figure Global Control to Target) Systems Revenue and Growth Rate (2017-2018)
Figure Global CTR (Control to Range) Systems Revenue and Growth Rate (2017-2018)
Table Global Bio-Artificial Pancreas Revenue and Revenue Share by End User (2017-2018)
Figure Global Medical Centers Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Bio-Artificial Pancreas Revenue by Regions (2017-2018)
Figure North America Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure North America Bio-Artificial Pancreas Revenue and Growth Rate (2017-2018)
Figure North America Bio-Artificial Pancreas by Countries (2017-2018)
Figure North America Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2018)
Figure United States Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure United States Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Canada Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Mexico Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Europe Bio-Artificial Pancreas Revenue and Growth Rate (2017-2018)
Figure Europe Bio-Artificial Pancreas by Countries (2017-2018)
Figure Europe Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2018)
Figure Germany Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Germany Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure France Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure UK Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Russia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Italy Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Rest of Europe Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Asia-Pacific Bio-Artificial Pancreas Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Bio-Artificial Pancreas by Countries (2017-2018)
Figure Asia-Pacific Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2018)
Figure China Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure China Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Japan Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Korea Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure India Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Southeast Asia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure South America Bio-Artificial Pancreas Revenue and Growth Rate (2017-2018)
Figure South America Bio-Artificial Pancreas by Countries (2017-2018)
Figure South America Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Brazil Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Argentina Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Columbia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Rest of South America Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Middle East and Africa Bio-Artificial Pancreas Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Bio-Artificial Pancreas by Countries (2017-2018)
Figure Middle East and Africa Bio-Artificial Pancreas Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Saudi Arabia Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure United Arab Emirates Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Egypt Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Nigeria Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure South Africa Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Turkey Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Bio-Artificial Pancreas Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2017-2018)
Table Medtronic Plc Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Insulet Corp Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffmann-La Roche Ltd Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bigfoot Biomedical Inc. Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dexcom Inc. Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Johnson & Johnson Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Tandem Diabetes Care Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Beta Bionics Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Inreda Diabetic B.V. Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cellnovo Bio-Artificial Pancreas Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Bio-Artificial Pancreas Market Share by Manufacturer
Figure Global Bio-Artificial Pancreas Revenue and Market Share by Manufacturer
Table Global Bio-Artificial Pancreas Price by Region (2017-2017)
Figure Top 5 Bio-Artificial Pancreas Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Bio-Artificial Pancreas Revenue (Millions USD) and Growth Rate (2018-2025)
Table Bio-Artificial Pancreas Market Forecast by Regions (2018-2025)
Figure North America Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure United States Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Canada Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Mexico Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Europe Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Germany Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure France Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure UK Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Russia Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Italy Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Rest of Europe Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Asia-Pacific Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure China Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Japan Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Korea Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure India Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Southeast Asia Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure South America Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Brazil Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Argentina Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Columbia Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Rest of South America Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Middle East and Africa Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Saudi Arabia Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure United Arab Emirates Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Egypt Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Nigeria Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure South Africa Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Turkey Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Bio-Artificial Pancreas Market Forecast (2018-2025)
Figure Global Bio-Artificial Pancreas Forecast by Type (2018-2025)
Figure Global Bio-Artificial Pancreas Market Share Forecast by Type (2018-2025)
Figure Global Bio-Artificial Pancreas Forecast by Type (2018-2025)
Figure Global Bio-Artificial Pancreas Forecast by End User (2018-2025)
Figure Global Bio-Artificial Pancreas Market Share Forecast by End User (2018-2025)
Figure Global Bio-Artificial Pancreas Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*